États-Unis · Plateformes & données · MarketBeat

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Crosses Above Two Hundred Day Moving Average - Here's What Happened

Publié par MarketBeat · États-Unis il y a 52 min

Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

Oramed Pharmaceuticals (NASDAQ:ORMP) Share Price Crosses Above Two Hundred Day Moving Average - Here's What Happened

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

À lire aussi

Fidelis Insurance Holdings boosts dividend by 46.7% to $0.22 a share

The Motley Fool

Is SpaceX Stock a Buy Before Its First Try at Catching a Starship Upper Stage?

Earnings call transcript: Ströer Q3 2026 gains on digital ad growth and steady outlook

Jensen Huang built Nvidia into a behemoth. His scandal puts the entire AI boom in jeopardy.

China's Ministry of State Security thrust into the spotlight by Nvidia CEO affair

SSAB Signs EUR 800 Million Revolving Credit Facility